Aravive (STU:VE11) Operating Cash Flow per Share : €-0.73 (TTM As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Aravive Operating Cash Flow per Share?

Aravive's operating cash flow per share for the three months ended in Sep. 2023 was €-0.12. Aravive's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.73.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -6.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 35.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 28.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Aravive's Operating Cash Flow per Share or its related term are showing as below:

STU:VE11' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -21.6 Med: 30.5 Max: 66.1
Current: -6.7

During the past 11 years, Aravive's highest 3-Year average Operating Cash Flow per Share Growth Rate was 66.10% per year. The lowest was -21.60% per year. And the median was 30.50% per year.

STU:VE11's 3-Year OCF Growth Rate is not ranked
in the Biotechnology industry.
Industry Median: 3.5 vs STU:VE11: -6.70

Aravive Operating Cash Flow per Share Historical Data

The historical data trend for Aravive's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aravive Operating Cash Flow per Share Chart

Aravive Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

Get a 7-Day Free Trial

-3.59

-1.33

-0.63

-1.42

-1.69

Aravive Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.63	-0.23	-0.22	-0.16	-0.12

Competitive Comparison of Aravive's Operating Cash Flow per Share

For the Biotechnology subindustry, Aravive's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aravive's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aravive's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Aravive's Price-to-Operating-Cash-Flow falls into.

Aravive Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Aravive's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	-61.435	/	36.372
	=	-1.69

Aravive's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Sep. 2023 )	=	Cash Flow from Operations (Q: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2023 )
	=	-9.19	/	76.093
	=	-0.12

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.73

Aravive Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Aravive's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Aravive (STU:VE11) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aravive Inc (STU:VE11) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

ARAV:USA VE11:Germany

Address

3730 Kirby Drive, River Oaks Tower, Suite 1200, Houston, TX, USA, 77098

Website

https://www.aravive.com

Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The company pipeline product Batiraxcept (formerly AVB-500) which is an ultra-high affinity decoy protein that binds to GAS6 and thereby prevents AXL signaling to inhibit metastasis and tumor growth and restore sensitivity to anti-cancer agents. Batiraxcept is currently being evaluated in multiple clinical trials.

Aravive (STU:VE11) Headlines

No Headlines